Compile Data Set for Download or QSAR
maximum 50k data
Found 1856 with Last Name = 'hiura' and Initial = 'y'
TargetHigh affinity nerve growth factor receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50524981(CHEMBL4562879)
Affinity DataIC50:  0.100nMAssay Description:Inhibition of N-terminal GST-tagged human TrkA kinase domain (436 to 790 residues) expressed in baculovirus expression system using biotin-poly-GT as...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSerine palmitoyltransferase 2(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50461646(CHEBI:582124 | Myriocin)
Affinity DataIC50:  0.130nMAssay Description:Inhibition of human SPT2 transfected in Freestyle293 cells using L-serine and palmitoyl-CoA as substrate preincubated for 60 mins followed by substra...More data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390216(CHEMBL2070151)
Affinity DataIC50:  0.160nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390219(CHEMBL2070148)
Affinity DataIC50:  0.160nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390213(CHEMBL2069316)
Affinity DataIC50:  0.200nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394224(CHEMBL2159167)
Affinity DataIC50:  0.210nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM529296(US11198695, Example II-233)
Affinity DataIC50:  0.224nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394211(CHEMBL2159165)
Affinity DataIC50:  0.280nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM529321(US11198695, Example II-258)
Affinity DataIC50:  0.285nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394221(CHEMBL2159158)
Affinity DataIC50:  0.290nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390228(CHEMBL2070161)
Affinity DataIC50:  0.290nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390232(CHEMBL2070157)
Affinity DataIC50:  0.310nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine palmitoyltransferase 2(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50461644(CHEMBL4228416)
Affinity DataIC50:  0.360nMAssay Description:Inhibition of human SPT2 transfected in Freestyle293 cells using L-serine and palmitoyl-CoA as substrate preincubated for 60 mins followed by substra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
LigandPNGBDBM529320(US11198695, Example II-257)
Affinity DataIC50:  0.409nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390225(CHEMBL2070140)
Affinity DataIC50:  0.430nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394214(CHEMBL2159162)
Affinity DataIC50:  0.430nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394214(CHEMBL2159162)
Affinity DataIC50:  0.430nMAssay Description:Displacement of [125I]PYY from mouse NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM529322(US11198695, Example II-259)
Affinity DataIC50:  0.439nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390222(CHEMBL2070137)
Affinity DataIC50:  0.460nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine palmitoyltransferase 2(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50461649(CHEMBL4225519)
Affinity DataIC50:  0.540nMAssay Description:Inhibition of human SPT2 transfected in Freestyle293 cells using L-serine and palmitoyl-CoA as substrate preincubated for 60 mins followed by substra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390220(CHEMBL2070147)
Affinity DataIC50:  0.540nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50390234(CHEMBL2070155)
Affinity DataIC50:  0.550nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394218(CHEMBL2159156)
Affinity DataIC50:  0.600nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM403547(US10335401, No. I-57)
Affinity DataIC50:  0.620nMAssay Description:A full-length human MGAT2 gene to which a Flag-tag had been added at the N-terminal was inserted into pFastBac (from Invitrogen). A recombinant bacul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM528979(US11198695, Example I-190 | US11198695, Example II...)
Affinity DataIC50:  0.706nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine palmitoyltransferase 2(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50461645(CHEMBL4228472)
Affinity DataIC50:  0.710nMAssay Description:Inhibition of human SPT2 transfected in Freestyle293 cells using L-serine and palmitoyl-CoA as substrate preincubated for 60 mins followed by substra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394223(CHEMBL2159166)
Affinity DataIC50:  0.730nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM403538(US10335401, No. I-47)
Affinity DataIC50:  0.730nMAssay Description:A full-length human MGAT2 gene to which a Flag-tag had been added at the N-terminal was inserted into pFastBac (from Invitrogen). A recombinant bacul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394228(CHEMBL2159171)
Affinity DataIC50:  0.800nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Mus musculus (Mouse))
Shionogi

Curated by ChEMBL
LigandPNGBDBM50394227(CHEMBL2159170)
Affinity DataIC50:  0.850nMAssay Description:Displacement of [125I]PYY from mouse NPY Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
LigandPNGBDBM528865(US11198695, Example I-77)
Affinity DataIC50:  1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529324(US11198695, Example II-261)
Affinity DataIC50:  1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529330(US11198695, Example II-267)
Affinity DataIC50:  1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529340(US11198695, Example II-277)
Affinity DataIC50:  1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529343(US11198695, Example II-280)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529344(US11198695, Example II-281)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529345(US11198695, Example II-282)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529346(US11198695, Example II-283)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529347(US11198695, Example II-284)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529353(US11198695, Example II-290)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529354(US11198695, Example II-291)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529266(US11198695, Example II-202)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529356(US11198695, Example II-294)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529357(US11198695, Example II-295)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529358(US11198695, Example II-296)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529359(US11198695, Example II-297)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529360(US11198695, Example II-298)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529362(US11198695, Example II-300)
Affinity DataIC50: <1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM529367(US11198695, Example II-305)
Affinity DataIC50:  1nMAssay Description:Solutions of the compounds of the present invention in DMSO were each aliquoted into 0.2-μL portions in a 384-well polystyrene microplate produc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
LigandPNGBDBM403562(US10335401, No. I-72)
Affinity DataIC50:  1nMAssay Description:A full-length human MGAT2 gene to which a Flag-tag had been added at the N-terminal was inserted into pFastBac (from Invitrogen). A recombinant bacul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1856 total ) | Next | Last >>
Jump to: